Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 18 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Keyword is Cost-Benefit Analysis [Clear All Filters]
Kidney health for everyone everywhere - from prevention to detection and equitable access to care..
Clin Nephrol. 93(3), 111-122.
(2020). Cost-Effectiveness of Empagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus at Increased Cardiovascular Risk in Greece..
Clin Drug Investig. 38(5), 417-426.
(2018). Impact of coil price knowledge by the operator on the cost of aneurysm coiling. A single center study..
J Neurointerv Surg. 10(6), 602-605.
(2018). THERAPY OF ENDOCRINE DISEASE: Denosumab vs bisphosphonates for the treatment of postmenopausal osteoporosis..
Eur J Endocrinol. 179(1), R31-R45.
(2018).
(2017).
(2017).
Prescription of antibiotics and awareness of antibiotic costs by paediatricians in two hospitals in Greece..
J Chemother. 26(1), 26-31.
(2014). Coronary artery bypass grafting with minimal versus conventional extracorporeal circulation; an economic analysis..
Int J Cardiol. 168(6), 5336-43.
(2013).
(2012).
Endoscopic management of occluded biliary uncovered metal stents: a multicenter experience..
World J Gastroenterol. 17(1), 98-104.
(2011). Payments and quality of care in private for-profit and public hospitals in Greece..
BMC Health Serv Res. 11, 234.
(2011). Pneumococcal vaccination in adults: does it really work?.
Respir Med. 105(12), 1776-83.
(2011). Myocardial perfusion scintigraphy in asymptomatic diabetic patients: a critical review..
Diabetes Metab Res Rev. 26(5), 336-47.
(2010).
(2010). An audit of tumour marker utilization in Greece..
Eur J Intern Med. 20(3), e66-9.
(2009).
(2009). Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with CHD and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study..
Nephrol Dial Transplant. 22(1), 118-27.
(2007). PCI and stable coronary heart disease--COURAGE to change our minds?.
Curr Vasc Pharmacol. 5(3), 173-4.
(2007).